Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 7/20 | 0.55 |
| ▸ | PLA2G2C | Q5R387 | 6/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19159189 | 0.84 | TLR2 (0.75) | TLR2 | |
| SCHEMBL19851715 | 0.79 | TLR2 (0.44) | TLR2PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL23695793 | 0.76 | MEN1 (0.63) | — | |
| SCHEMBL28459656 | 0.75 | USP2 (0.58) | TLR2PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL29115231 | 0.75 | USP2 (0.58) | TLR2PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL12449393 | 0.75 | TLR2 (0.59) | TLR2PLA2G2CCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL23945661 | 0.74 | MEN1 (0.59) | — | |
| SCHEMBL25831070 | 0.73 | MEN1 (0.52) | HTTCES2 | |
| SCHEMBL21046018 | 0.71 | USP2 (0.68) | PLA2G2CUSP2HTTCES2LPAR5 | |
| SCHEMBL21046008 | 0.71 | USP2 (0.68) | PLA2G2CUSP2HTTCES2LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018026866-A1 | LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION | NEUROPORE THERAPIES, INC. (US) | 2018-02-08 | — | — | WO | disclosed |